How to outsmart the cold tumor microenvironment: Design of STING ligand nanoparticles for improved cancer immunotherapy
Marija Petrovic,
Stoyan Tankov,
Martin Kiening,
Yakkala Chakradhar,
Duran Rafael,
Paul R. Walker,
Gerrit Borchard,
Olivier Jordan
Affiliations
Marija Petrovic
School of Pharmaceutical Sciences, University of Geneva, Geneva CH-1206, Switzerland; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva CH-1206, Switzerland
Stoyan Tankov
Translational Research Centre in Oncohaematology, University of Geneva, Geneva, Switzerland
Martin Kiening
School of Pharmaceutical Sciences, University of Geneva, Geneva CH-1206, Switzerland; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva CH-1206, Switzerland
Yakkala Chakradhar
Service de Radiodiagnostic et Radiologie Interventionnelle, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Duran Rafael
Service de Radiodiagnostic et Radiologie Interventionnelle, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Paul R. Walker
Translational Research Centre in Oncohaematology, University of Geneva, Geneva, Switzerland
Gerrit Borchard
School of Pharmaceutical Sciences, University of Geneva, Geneva CH-1206, Switzerland; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva CH-1206, Switzerland
Olivier Jordan
School of Pharmaceutical Sciences, University of Geneva, Geneva CH-1206, Switzerland; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva CH-1206, Switzerland; Corresponding author at: School of Pharmaceutical Sciences, University of Geneva, Geneva CH-1206, Switzerland.
